医学
泌尿生殖系统
更年期
药方
妇科
绝经后妇女
重症监护医学
性器官
内科学
遗传学
药理学
生物
作者
Shanice Cox,Ryan Nasseri,Rachel Rubin,Yahir Santiago‐Lastra
标识
DOI:10.1016/j.mcna.2022.10.017
摘要
Introduced in 2014, genitourinary syndrome of menopause (GSM) describes a variety of unpleasant genital, sexual and urinary symptoms that can either be isolated or coexisting and are not related to other medical conditions. GSM is a chronic and progressive condition that requires early recognition and appropriate management to preserve urogenital health. Despite the importance of early detection and treatment, the condition is consistently underdiagnosed and undertreated. Herein, we emphasize how to diagnose GSM in postmenopausal, hypoestrogenic, and hypoandrogenic women and summarize evidence-based treatments focusing on prescription treatments and adjunctive therapies.
科研通智能强力驱动
Strongly Powered by AbleSci AI